Low LDL and Bleeding Risk; Improved HoFH Life Expectancy; ANGPTL4 mAb Progress



(MedPage Today) — Low LDL cholesterol was associated with an increased risk of bleeding in patients receiving anticoagulation for venous thromboembolism (VTE). (JAMA Network Open)
Among oral anticoagulants used for secondary VTE prevention, apixaban…



Source link : https://www.medpagetoday.com/cardiology/prevention/115567

Author :

Publish date : 2025-05-13 18:22:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version